Adjuvant Hepatic Arterial Infusional Chemotherapy with 5-Fluorouracil and Cisplatin after Curative Resection of Hepatocellular Carcinoma
- Authors
- Kim, Do Young; Ahn, Sang Hoon; Kim, Seung Up; Choi, Sae Byeol; Lee, Kwang-Hun; Park, Mi Sook; Park, Jun Yong; Lee, Do Yun; Han, Kwang-Hyub; Kim, Kyung Sik
- Issue Date
- 2011
- Publisher
- KARGER
- Keywords
- Hepatocellular carcinoma; Adjuvant therapy; Hepatic arterial infusional chemotherapy
- Citation
- ONCOLOGY, v.81, no.3-4, pp.184 - 191
- Indexed
- SCIE
SCOPUS
- Journal Title
- ONCOLOGY
- Volume
- 81
- Number
- 3-4
- Start Page
- 184
- End Page
- 191
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/115032
- DOI
- 10.1159/000333827
- ISSN
- 0030-2414
- Abstract
- Objectives: We investigated whether adjuvant hepatic arterial infusional chemotherapy (HAIC) with 5-fluorouracil (5FU) and cisplatin reduces the recurrence of hepatocellular carcinoma (HCC) after curative resection. Methods: Between January 2006 and December 2008, 31 HCC patients received four cycles of adjuvant HAIC with 5-FU and cisplatin via port system after curative resection. During the same period, 62 patients, who did not take any adjuvant therapy, were selected as controls. Results: Tumor characteristics, such as distribution of TNM stage, pathologic differentiation, portal vein invasion, or microscopic invasion did not differ between control and adjuvant groups. During follow-up, recurrence developed in 11 adjuvant (35.5%) and 24 control patients (38.7%; p = 0.823). Tumor progression after recurrence was the cause of death in 2 adjuvant (28.6%) and 7 control patients (38.8%; p = 0.912). The 2-year recurrence rate was 9.1% in the adjuvant group and 4.2% in the control group, with the median recurrence-free survival time being 10.5 and 7.5 months, respectively (p = 0.324). The 3-year cumulative survival rate was 73.3% in the adjuvant group and 68.3% in the control group (p = 0.355). Conclusion: Adjuvant HAIC with 5-FU and cisplatin did not offer any beneficial effect on the recurrence after curative resection of HCC. Copyright (C) 2011 S. Karger AG, Basel
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.